ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma
Phase 1/2 Completed
19 enrolled
Daratumumab in Treating Transplant-Eligible Patients With Multiple Myeloma
Phase 2 Completed
49 enrolled 15 charts
BMT
Phase NA Completed
10 enrolled
LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple Myeloma
Phase 2 Completed
15 enrolled 26 charts
Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma
Phase 2 Completed
30 enrolled 13 charts
Biomarkers of AKI in Patients Receiving Daratumumab
Completed
20 enrolled
A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency
Phase 2 Completed
55 enrolled
Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma
Phase 3 Completed
514 enrolled
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
Phase 1 Completed
9 enrolled
IFM2010-02
Phase 2 Completed
63 enrolled
Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
Completed
56 enrolled
Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation
Phase 2 Completed
43 enrolled 9 charts
Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant
Phase 2 Completed
42 enrolled 11 charts
Outcome of Multiple Myeloma Associated With Autoimmune Hemolytic Anemia
Phase NA Completed
66 enrolled
Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma
Phase 2 Completed
46 enrolled 10 charts
Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma
Phase 2 Completed
46 enrolled 13 charts
Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Patients With Multiple Myeloma
Phase 2 Completed
30 enrolled 11 charts
HO95
Phase 3 Completed
1,503 enrolled
SOSAM
Phase NA Completed
20 enrolled
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 1/2 Completed
25 enrolled
Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma
Phase 2 Completed
77 enrolled 17 charts
Health Through Activity: A Pilot Study of a Rehabilitation Intervention for People Living With Multiple Myeloma
Phase NA Completed
5 enrolled 10 charts
IFM2012-03
Phase 2 Completed
32 enrolled
iPREFER
Completed
9 enrolled
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
Completed
146 enrolled
PCD
Phase 2 Completed
100 enrolled
Determining The Impact Of Distance Reiki On Patient Reported QOL And Immunity Among Multiple Myeloma Patients
Phase NA Completed
30 enrolled
MCSF-MYELOME
Phase NA Completed
111 enrolled
SINE
Phase 1 Completed
52 enrolled
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
Phase 2 Completed
62 enrolled 15 charts
Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantation for Multiple Myeloma
Phase NA Completed
31 enrolled 7 charts
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Phase 2 Completed
25 enrolled 6 charts
Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma
Phase 2 Completed
12 enrolled 8 charts
High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma
Phase NA Completed
62 enrolled
Multiple Myeloma Prognostic Indices
Completed
48 enrolled
Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma
Phase 2 Completed
66 enrolled
Financial Difficulty in Patients With Blood Cancer
Completed
218 enrolled
PROFAST
Phase NA Completed
23 enrolled
ASCENT
Phase NA Completed
51 enrolled 8 charts
(Mel/MelVel)
Phase 3 Completed
148 enrolled 12 charts
AVR-CHEMO
Phase NA Completed
150 enrolled
Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma
Phase 2 Completed
23 enrolled
Evaluating Effectiveness of Powered Drill Bone Marrow Biopsy
Phase NA Completed
100 enrolled 8 charts
Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib
Phase 2 Completed
165 enrolled 15 charts
Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells
Completed
146 enrolled
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
Completed
11 enrolled
A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization
Phase 1 Completed
20 enrolled
Perspectives of Subcutaneous Velcade at Home of Patients With Myeloma.
Completed
10 enrolled
DILEMMA
Completed
188 enrolled
Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma
Phase NA Completed
20 enrolled